Area of research
Oncology · Public Health, Environmental and Occupational Health
Research interest
Research interests include Cancer Risks and Factors, Nutritional Studies and Diet, Global Cancer Incidence and Screening, and Ovarian cancer diagnosis and treatment.
Alcohol intake and pancreatic cancer risk: An analysis from 30 prospective studies across Asia, Australia, Europe, and North America
Alcohol and smoking habits in association with hepatocellular carcinoma risk
Associations between degree of food processing and colorectal cancer risk in a large‐scale European cohort
Associations between cardiometabolic comorbidities and mortality in adults with cancer: multinational cohort study
Sex Disparities and Female Reproductive and Hormonal Factors Associated with Risk of Pancreatic Cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) Cohort
Reproductive Factors, Sex Hormone Levels, and Differentiated Thyroid Cancer Risk: A Mendelian Randomization Study
Quantifying the environmental and food biodiversity impacts of ultra-processed foods: evidence from the European Prospective Investigation into Cancer and Nutrition (EPIC) study
Identifying Metabolomic Mediators of the Physical Activity and Colorectal Cancer Relationship
Association Between Dietary Intake and Blood Concentrations of One-Carbon-Metabolism-Related Nutrients in European Prospective Investigation into Cancer and Nutrition
Biodiverse diets present co-benefits for greenhouse gas emissions, land use, mortality rates and nutritional adequacy in Europe
Development and validation of a risk prediction model for premenopausal breast cancer in 19 cohorts
Can serum metabolic signatures inform on the relationship between healthy lifestyle and colon cancer risk?
Intake of total, classes, and subclasses of (poly)phenols and risk of lymphoid neoplasms: a prospective analysis in the EPIC cohort
Synergies between food biodiversity, processing levels, and the EAT-Lancet diet for nutrient adequacy and environmental sustainability: a multiobjective optimization using the European Prospective Investigation into Cancer and Nutrition cohort
The 3V score and joint associations of low ultra-processed food, biodiverse and plant-based diets on colorectal cancer risk: results from the European Prospective Investigation into Cancer and Nutrition (EPIC) study
Food consumption by degree of food processing and risk of type 2 diabetes mellitus: a prospective cohort analysis of the European Prospective Investigation into Cancer and Nutrition (EPIC)
Hepatic steatosis, metabolic dysfunction and risk of mortality: findings from a multinational prospective cohort study
Association of circulating fatty acids with cardiovascular disease risk: analysis of individual-level data in three large prospective cohorts and updated meta-analysis
Dietary intake of plant- and animal-derived protein and incident cardiovascular diseases: the pan-European EPIC-CVD case–cohort study
Healthy lifestyle change and all-cause and cancer mortality in the European Prospective Investigation into Cancer and Nutrition cohort
Nutritional quality of diet characterized by the Nutri-Score profiling system and cardiovascular disease risk: a prospective study in 7 European countries
Lifestyle changes in middle age and risk of cancer: evidence from the European Prospective Investigation into Cancer and Nutrition
On the use of the healthy lifestyle index to investigate specific disease outcomes
BMI and breast cancer risk around age at menopause
Inflammation and gut barrier function-related genes and colorectal cancer risk in western European populations
Circulating endogenous sex steroids and risk of differentiated thyroid carcinoma in men and women
Impact of pre‐existing cardiometabolic diseases on metastatic cancer stage at diagnosis: a prospective multinational cohort study
Perturbations in the blood metabolome up to a decade before prostate cancer diagnosis in 4387 matched case–control sets from the European Prospective Investigation into Cancer and Nutrition
Pre‐diagnostic plasma advanced glycation end‐products and soluble receptor for advanced glycation end‐products and mortality in colorectal cancer patients
Adiposity assessed close to diagnosis and prostate cancer prognosis in the EPIC study